Companies · Other Health Care

TargetCath, Inc.

MINNEAPOLIS · Other Health Care

Diligence memoA one-page analyst read on TargetCath, Inc. — recommendation, valuation, rhythm, risks.
$120K
Total raised · real
1
Rounds
0.9×
Latest step-up
Top 97%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Sat Feb 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

TargetCath, Inc. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.27× the median modeled value of Pre-Seed Other Health Care companies in 2025–2027 (115 peers) — value vs value, same stage and era.
Active
  • Last raise 4 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

TargetCath, Inc. is one of 5376 Other Health Care companies tracked from MINNEAPOLIS. By capital raised it ranks in the long tail (ahead of 4% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2
Investors (latest)
2025
Year incorporated
2026-02-28
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125K$250K$375K$500KPre-Seed · 2026-02-28 Raised $120K (real) Modeled valuation $222K (est)$120K$222KPre-Seed2026Pre-Seed · 2026-02-28 Raised $108K (real) Modeled valuation $199K (est)$108K$199KPre-Seed2026+$108KCumulative $228K

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$120K · 2026
Pre-Seed extension$108K · 2026

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$222K
Base estimate est.
$75K
Conservative case
$451K
Upside case
$667K
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $222K · 2026-02-282026Pre-Seed · modeled $199K · 2026-02-282026
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
0.3 yr
Elapsed time used
0.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
0.3 yr
On record since
2026
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.0× of median
This company$120K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.3× of median
This company$108K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$222K
Sector median$22.1M

Raised more than 4% of sector peers (real $). Modeled value above 1% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #113 of 115.

This companyCohort peer
$100K$1.0M$10.0M$10K$100K$1.0M$10.0MCapital raised (log)352 Ingredients LLC · Pre-Seed Raised $1.0M · modeled $3.1M (est)Bmh North Mississippi Imaging Services Llc · Pre-Seed Raised $1.9M · modeled $2.9M (est)ClearPath Vascular, Inc. · Pre-Seed Raised $1.0M · modeled $2.8M (est)Imagen Silvera Support Services, LLC · Pre-Seed Raised $938K · modeled $2.8M (est)Mens LLC · Pre-Seed Raised $1.0M · modeled $2.7M (est)Apnomed, Inc. · Pre-Seed Raised $1.0M · modeled $2.7M (est)Livmor Inc. · Pre-Seed Raised $1.5M · modeled $2.7M (est)Imagen Ingenious Dentistry Support Services, LLC · Pre-Seed Raised $929K · modeled $2.6M (est)Livonia Surgery Center, LLC · Pre-Seed Raised $980K · modeled $2.4M (est)Town Doc, Inc. · Pre-Seed Raised $1.0M · modeled $2.3M (est)Imagen Toothologie Support Services, LLC · Pre-Seed Raised $869K · modeled $2.1M (est)Imagen Koopah Support Services, LLC · Pre-Seed Raised $905K · modeled $2.1M (est)TargetCath, Inc. (this company) Raised $120K · modeled $222K (est)TargetCath, Inc.
CompanyStageRaised · realValue · estvs peer med.
352 Ingredients LLCPre-Seed$1.0M$3.1M3.78×
Bmh North Mississippi Imaging Services LlcPre-Seed$1.9M$2.9M3.56×
ClearPath Vascular, Inc.Pre-Seed$1.0M$2.8M3.38×
Imagen Silvera Support Services, LLCPre-Seed$938K$2.8M3.35×
Mens LLCPre-Seed$1.0M$2.7M3.32×
Apnomed, Inc.Pre-Seed$1.0M$2.7M3.28×
Livmor Inc.Pre-Seed$1.5M$2.7M3.26×
Imagen Ingenious Dentistry Support Services, LLCPre-Seed$929K$2.6M3.18×
Livonia Surgery Center, LLCPre-Seed$980K$2.4M2.92×
Town Doc, Inc.Pre-Seed$1.0M$2.3M2.81×
Imagen Toothologie Support Services, LLCPre-Seed$869K$2.1M2.57×
Imagen Koopah Support Services, LLCPre-Seed$905K$2.1M2.49×
TargetCath, Inc. this companyPre-Seed$120K$222K0.27×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$120K2026-02-28$667K$222K90%
Pre-Seed$108K2026-02-28$597K$199K90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$120K2026-02-28
    • First recorded raise — entered as Pre-Seed.
    • 3 investors on this round.
  2. Pre-Seed$108K2026-02-28
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 2 investors on this round.
Intelligence
Modeled next raise
$108K
Modeled next size est.range $108K$172K
0.9×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Carmelo Panetta2026-02
Registry & provenance

TargetCath, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
2118265
SEC CIK
2025
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Cornell Pharmacy, LLCOther Health CarePre-Seed$120K$188Ksame sector · same stage
Imaging Ventures, LlcOther Health CarePre-Seed$120K$188Ksame sector · same stage
Legacy Pharmacy, LLCOther Health CarePre-Seed$120K$188Ksame sector · same stage
Select Pharma, LLCOther Health CarePre-Seed$120K$188Ksame sector · same stage
Boulder Spine Center, LLCOther Health CarePre-Seed$121K$190Ksame sector · same stage
DripDoc LLCOther Health CarePre-Seed$117K$707Ksame sector · same stage
Central Indiana URS Consumables, LLCOther Health CarePre-Seed$116K$483Ksame sector · same stage
ReBrand Consulting Services LLCOther Health CarePre-Seed$125K$294Ksame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
XCath, Inc.Other Health CareSeries A$107.6M90%
XableCath Inc.Other Health CareSeed$29.1M88%
ImmuneTarget, Inc.Other Health CarePre-Seed$18.7M86%
Mercator Medsystems IncOther Health CareSeries A$289.2M85%
PTSH Holdings, LLCOther Health CareSeries C$967.1M84%
Lynx Dx, Inc.Other Health CarePre-Seed$28.5M83%
CathBuddy, Inc.Other Health CareSeries A$60.6M83%
AdvocateMH Inc.Other Health CareSeries A$23.8M83%
Frequently asked
How much funding has TargetCath, Inc. raised?
TargetCath, Inc. has raised approximately $120K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is TargetCath, Inc.'s estimated valuation?
Provath's modeled valuation for TargetCath, Inc. is approximately $222K (modeled range $75K–$451K). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is TargetCath, Inc. at?
TargetCath, Inc.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Sat Feb 28.
What does TargetCath, Inc. do and where is it based?
TargetCath, Inc. operates in the Other Health Care sector, based in MINNEAPOLIS.
Explore related

See where TargetCath, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at TargetCath, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.